Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Placental hypoxia-induced alterations in vascular function, morphology, and endothelial barrier integrity

Abstract

Preeclampsia (PE) is a pregnancy-related disorder characterized by hypertension and proteinuria that affects 3–10% of all pregnancies. Although its pathophysiology remains obscure, placental hypoxia-induced oxidative stress and alterations in vascular function, morphology, and endothelial barrier integrity are considered to play a key role in the development of preeclampsia. In this study, placental villous explants of noncomplicated placentae and BeWo cells were subjected to hypoxia. The effect of placental hypoxic-conditioned medium (HCM) on intraluminal-induced contraction and endothelial barrier integrity in chorionic arteries was investigated using pressure myography. The impact of BeWo cell HCM on endothelial cell viability, reactive oxygen species formation and inflammation was also determined. Alterations in arterial morphology and contractile responsiveness to the thromboxane A2 analog (U46619) after exposure to placental HCM were examined immunohistochemically and by wire myography, respectively. Intraluminal administration of placental HCM induced vasoconstriction and increased the endothelial permeability for KCl, which was concentration-dependently prevented by quercetin. Placental and BeWo cell HCMs decreased endothelial cell viability, increased the production of reactive oxygen species and enhanced the secretion of IL-6 and IL-8. The cross-sectional area of the arterial media was increased upon exposure to placental HCM, which was associated with increased vascular proliferation and contractile responsiveness to U46619, and all of these effects were prevented by the antioxidants quercetin and RRR-α-tocopherol. This study is the first to comprehensively demonstrate the link between factors secreted by placental cells in response to hypoxia and vascular abnormalities and paves the way for new diagnostic approaches and therapies to better protect the maternal vasculature during and after a preeclampsia-complicated pregnancy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Zarate A, Saucedo R, Valencia J, Manuel L, Hernandez M. Early disturbed placental ischemia and hypoxia creates immune alteration and vascular disorder causing preeclampsia. Arch Med Res. 2014;45:519–24.

    PubMed  Google Scholar 

  2. Burton GJ, Redman CW, Roberts JM, Moffett A. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019;366:l2381.

    PubMed  Google Scholar 

  3. Yu W, Gao W, Rong D, Wu Z, Khalil RA. Molecular determinants of microvascular dysfunction in hypertensive pregnancy and preeclampsia. Microcirculation. 2018. https://doi.org/10.1111/micc.12508):e12508.

  4. Sánchez-Aranguren LC, Prada CE, Riaño-Medina CE, Lopez M. Endothelial dysfunction and preeclampsia: role of oxidative stress. Front Physiol. 2014;5:372.

    PubMed  PubMed Central  Google Scholar 

  5. Vangrieken P, Vanterpool SF, van Schooten FJ, Al-Nasiry S, Andriessen P, Degreef E, et al. Histological villous maturation in placentas of complicated pregnancies. Histol Histopathol. 2020. https://doi.org/10.14670/HH-18-205):18205.

  6. Vangrieken P, Al-Nasiry S, Janssen GMJ, Weseler AR, Spaanderman ME, Bast A, et al. The direct and sustained consequences of severe placental hypoxia on vascular contractility. PLoS ONE. 2018;13:e0202648.

    PubMed  PubMed Central  Google Scholar 

  7. Sahay AS, Patil VV, Sundrani DP, Joshi AA, Wagh GN, Gupte SA, et al. A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia. Hypertens Res. 2014;37:753.

    CAS  PubMed  Google Scholar 

  8. Brennan LJ, Morton JS, Davidge ST. Vascular dysfunction in preeclampsia. Microcirculation. 2014;21:4–14.

    PubMed  Google Scholar 

  9. Leik CE, Walsh SW. Neutrophils infiltrate resistance-sized vessels of subcutaneous fat in women with preeclampsia. Hypertension. 2004;44:72–77.

    CAS  PubMed  Google Scholar 

  10. Shah DA, Khalil RA. Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia. Biochem Pharmacol. 2015;95:211–26.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Crews JK, Herrington JN, Granger JP, Khalil RA. Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat. Hypertension. 2000;35:367–72.

    CAS  PubMed  Google Scholar 

  12. Gilbert JS, Babcock SA, Granger JP. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension. 2007;50:1142–7.

    CAS  PubMed  Google Scholar 

  13. Fushima T, Sekimoto A, Minato T, Ito T, Oe Y, Kisu K, et al. Reduced uterine perfusion pressure (RUPP) model of preeclampsia in mice. PLoS ONE. 2016;11:e0155426.

    PubMed  PubMed Central  Google Scholar 

  14. Rigotti A. Absorption, transport, and tissue delivery of vitamin E. Mol Aspect Med. 2007;28:423–36.

    CAS  Google Scholar 

  15. Şimşek M, Naziroǧlu M, Şimşek H, Cay M, Aksakal M, Kumru S. Blood plasma levels of lipoperoxides, glutathione peroxidase, beta carotene, vitamin A and E in women with habitual abortion. Cell Biochem Funct: Cell Biochem its modulation Act agents or Dis. 1998;16:227–31.

    Google Scholar 

  16. Mesdaghinia E, Mohammad-Ebrahimi B, Foroozanfard F, Banafshe HR. The effect of vitamin E and aspirin on the uterine artery blood flow in women with recurrent abortion: a single-blind randomized controlled trial. Int J Reprod BioMed. 2017;15:635.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Vogiatzoglou A, Mulligan AA, Lentjes MA, Luben RN, Spencer JP, Schroeter H, et al. Flavonoid intake in European adults (18 to 64 years). PLoS ONE. 2015;10.

  18. Kozłowska A, Szostak-Węgierek D. Flavonoids—food sources, health benefits, and mechanisms involved. In: Bioactive molecules in food reference series in phytochemistry. Cham: Springer; 2018.

  19. Debier C. Vitamin E during pre‐and postnatal periods. Vitam Hormones. 2007;76:357–73.

    CAS  Google Scholar 

  20. McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J. 2008;156:918–30.

    PubMed  Google Scholar 

  21. Brennan L, Morton JS, Quon A, Davidge ST. Postpartum vascular dysfunction in the reduced uteroplacental perfusion model of preeclampsia. PLoS ONE. 2016;11:e0162487.

    PubMed  PubMed Central  Google Scholar 

  22. Ramsay JE, Stewart F, Greer IA, Sattar N. Microvascular dysfunction: a link between pre-eclampsia and maternal coronary heart disease. BJOG. 2003;110:1029–31.

    PubMed  Google Scholar 

  23. Chambers JC, Fusi L, Malik IS, Haskard DO, De Swiet M, Kooner JS. Association of maternal endothelial dysfunction with preeclampsia. JAMA. 2001;285:1607–12.

    CAS  PubMed  Google Scholar 

  24. Wang Y, Zhao S. Vasoactivators and placental vasoactivity. Morgan & Claypool Life Sciences, San Rafael; 2010.

  25. Boots AW, Veith C, Albrecht C, Bartholome R, Drittij M-J, Claessen SM, et al. The dietary antioxidant quercetin reduces hallmarks of bleomycin-induced lung fibrogenesis in mice. BMC Pulm Med. 2020;20:1–16.

    Google Scholar 

  26. Yu W, Jia L, Park SK, Li J, Gopalan A, Simmons-Menchaca M, et al. Anticancer actions of natural and synthetic vitamin E forms: RRR-α-tocopherol blocks the anticancer actions of γ-tocopherol. Mol Nutr food Res. 2009;53:1573–81.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Sava RI, March KL, Pepine CJ. Hypertension in pregnancy: Taking cues from pathophysiology for clinical practice. Clin Cardiol. 2018;41:220–7.

    PubMed  PubMed Central  Google Scholar 

  28. LaMarca B, Amaral LM, Harmon AC, Cornelius DC, Faulkner JL, Cunningham MW Jr. Placental ischemia and resultant phenotype in animal models of preeclampsia. Curr Hypertens Rep. 2016;18:38.

  29. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet. 2001;357:53–56.

    CAS  PubMed  Google Scholar 

  30. Henriques AC, Carvalho FH, Feitosa HN, Macena RH, Mota RM, Alencar JC. Endothelial dysfunction after pregnancy-induced hypertension. Int J Gynaecol Obstet. 2014;124:230–4.

    PubMed  Google Scholar 

  31. Palei AC, Spradley FT, Warrington JP, George EM, Granger JP. Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology. Acta Physiol. 2013;208:224–33.

    CAS  Google Scholar 

  32. George EM, Granger JP. Endothelin: key mediator of hypertension in preeclampsia. Am J Hypertens. 2011;24:964–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Fiore G, Florio P, Micheli L, Nencini C, Rossi M, Cerretani D, et al. Endothelin-1 triggers placental oxidative stress pathways: putative role in preeclampsia. J Clin Endocrinol Metab. 2005;90:4205–10.

    CAS  PubMed  Google Scholar 

  34. Dong F, Zhang X, Wold LE, Ren Q, Zhang Z, Ren J. Endothelin-1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: role of ETB receptor, NADPH oxidase and caveolin-1. Br J Pharm. 2005;145:323–33.

    CAS  Google Scholar 

  35. Echeverria C, Eltit F, Santibanez JF, Gatica S, Cabello-Verrugio C, Simon F. Endothelial dysfunction in pregnancy metabolic disorders. Biochim Biophys Acta Mol Basis Dis. 2020;1866:165414.

    CAS  PubMed  Google Scholar 

  36. Nakamura M, Sekizawa A, Purwosunu Y, Okazaki S, Farina A, Wibowo N. et al. Cellular mRNA expressions of anti‐oxidant factors in the blood of preeclamptic women. Prenat Diagn. 2009;29:691–6.

    CAS  PubMed  Google Scholar 

  37. Cohen JM, Kramer MS, Platt RW, Basso O, Evans RW, Kahn SR. The association between maternal antioxidant levels in midpregnancy and preeclampsia. Am J Obstet Gynecol. 2015;213:695 e691–613.

    Google Scholar 

  38. Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation. 2011;123:2856–69.

    PubMed  Google Scholar 

  39. Wang Y, Lewis DF, Gu Y, Zhang Y, Alexander JS, Granger DN. Placental trophoblast-derived factors diminish endothelial barrier function. J Clin Endocrinol Metab. 2004;89:2421–8.

    CAS  PubMed  Google Scholar 

  40. LaMarca B, Speed J, Fournier L, Babcock SA, Berry H, Cockrell K, et al. Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade. Hypertension. 2008;52:1161–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Matthiesen L, Berg G, Ernerudh J, Ekerfelt C, Jonsson Y, Sharma S. Immunology of preeclampsia. Chem Immunol Allergy. 2005;89:49–61.

    CAS  PubMed  Google Scholar 

  42. Possomato-Vieira JS, Khalil RA. Mechanisms of endothelial dysfunction in hypertensive pregnancy and preeclampsia. Adv Pharm. 2016;77:361–431.

    CAS  Google Scholar 

  43. Lockwood CJ, Yen CF, Basar M, Kayisli UA, Martel M, Buhimschi I, et al. Preeclampsia-related inflammatory cytokines regulate interleukin-6 expression in human decidual cells. Am J Pathol. 2008;172:1571–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  44. LaMarca B, Brewer J, Wallace K. IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate? Int J Interferon, Cytokine Mediator Res. 2011;2011:59.

    Google Scholar 

  45. Majed BH, Khalil RA. Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn. Pharmacol Rev. 2012;64:540–82.

    CAS  PubMed  PubMed Central  Google Scholar 

  46. Wang Y, Gu Y, Granger DN, Roberts JM, Alexander JS. Endothelial junctional protein redistribution and increased monolayer permeability in human umbilical vein endothelial cells isolated during preeclampsia. Am J Obstet Gynecol. 2002;186:214–20.

    CAS  PubMed  Google Scholar 

  47. Jia G, Aroor AR, Meininger GA, Sowers JR. Glucose, insulin and potential strategies of vascular stiffening. In: Blood pressure and arterial wall mechanics in cardiovascular diseases. Springer; 2014. p. 423–34.

  48. Belfort MA, Saade GR, Suresh M, Kramer W, Vedernikov YP. Effects of selected vasoconstrictor agonists on isolated omental artery from premenopausal nonpregnant women and from normal and preeclamptic pregnant women. Am J Obstet Gynecol. 1996;174:687–93.

    CAS  PubMed  Google Scholar 

  49. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335:974.

    PubMed  PubMed Central  Google Scholar 

  50. Brandao AH, Felix LR, Patricio Edo C, Leite HV, Cabral AC. Difference of endothelial function during pregnancies as a method to predict preeclampsia. Arch Gynecol Obstet. 2014;290:471–7.

    PubMed  Google Scholar 

  51. Murphy MS, Vignarajah M, Smith GN. Increased microvascular vasodilation and cardiovascular risk following a pre-eclamptic pregnancy. Physiol Rep. 2014;2:11.

    Google Scholar 

  52. Davis KR, Ponnampalam J, Hayman R, Baker PN, Arulkumaran S, Donnelly R. Microvascular vasodilator response to acetylcholine is increased in women with pre-eclampsia. BJOG. 2001;108:610–4.

    CAS  PubMed  Google Scholar 

  53. Sooranna SR, Oteng-Ntim E, Meah R, Ryder TA, Bajoria R. Characterization of human placental explants: morphological, biochemical and physiological studies using first and third trimester placenta. Hum Reprod. 1999;14:536–41.

    CAS  PubMed  Google Scholar 

  54. Di Santo S, Malek A, Sager R, Andres AC, Schneider H. Trophoblast viability in perfused term placental tissue and explant cultures limited to 7–24 h. Placenta. 2003;24:882–94.

    PubMed  Google Scholar 

  55. Place TL, Domann FE, Case AJ. Limitations of oxygen delivery to cells in culture: an underappreciated problem in basic and translational research. Free Radic Biol Med. 2017;113:311–22.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This study was funded by the NUTRIM Graduate Program and supported by the external source: “Fonds gezond geboren”. No additional external funding was received for this study.

Author information

Authors and Affiliations

Authors

Contributions

PV designed the study, performed the research, analyzed the data and wrote the paper. AHVR, SA, AB, PMHS, and FJS were involved in the supervision of the research. GMJJ, UR, AC, DV, and YCWP contributed to the experiments and analysis. AHVR and PMHS were involved in conceptualizing the research and writing the manuscript.

Corresponding author

Correspondence to Philippe Vangrieken.

Ethics declarations

Conflict of interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vangrieken, P., Remels, A.H.V., Al-Nasiry, S. et al. Placental hypoxia-induced alterations in vascular function, morphology, and endothelial barrier integrity. Hypertens Res 43, 1361–1374 (2020). https://doi.org/10.1038/s41440-020-0528-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41440-020-0528-8

Keywords

This article is cited by

Search

Quick links